To use all functions of this page, please activate cookies in your browser.
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
ThioTEPA
N,N'N'-triethylenethiophosphoramide (ThioTEPA) is a cancer chemotherapeutic member of the alkylating agent group, now in use for over 50 years. It is a stable derivative of N,N',N''- triethylenephosphoramide (TEPA). It is mostly used to treat breast cancer, ovarian cancer and bladder cancer. It is also used as conditioning for Bone marrow transplantation. Its main toxicity is myelosuppression. References
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "ThioTEPA". A list of authors is available in Wikipedia. |
- Biological machine produces its own building blocks - Researchers have for the first time developed a genome the size of a minimal cell that can copy itself
- How Insulin in the Brain May Suppress the Subjective Feeling of Hunger
- Scienion US Inc. receives ISO 13485 certification
- Researchers find link between dementia and atrial cardiopathy - The study is important for people without symptomatic cardiac disease
- Luc_Ciompi